P024. Are patients diagnosed with breast cancer aged 70 and above receiving gold standard care

(55/918). Of the 55 patients, 22 patients were excluded (Eleven patients had mastectomy, six had more than two nodes involved, four had neo adjuvant chemotherapy and one declined surgery) leaving 33 patients. Therefore 2.2% (33/1499) of the cohort met the inclusion criteria for the ACOSOG Z0011 trial. Conclusions: In this observational study, only 2.2% (33/1499) of the patients were identified as per the ZOO11 criteria. This means only a very few number of patients could be spared from axillary lymph node dissection. So clearly it is not a practice changing trial in the axillary surgical management of our cohort of patients.